Sacituzumab Govitecan for Advanced Esophageal Squamous Cell Carcinoma

Clinical trial NCT06329869 · RECRUITING

Trial details

NCT number: NCT06329869
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Squamous Cell Carcinoma

Start date: 2024-08-01
Primary completion: 2026-11-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.